Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Findings From the EXTEND-DAPT Study

被引：10
|
作者：
Faridi, Kamil F. [1 ,2 ]
Tamez, Hector [2 ]
Strom, Jordan B. [2 ]
Song, Yang [4 ]
Butala, Neel M. [3 ]
Shen, Changyu [2 ]
Secemsky, Eric A. [2 ]
Mauri, Laura [4 ,5 ]
Curtis, Jeptha P. [1 ]
Gibson, C. Michael [2 ,4 ]
Yeh, Robert W. [2 ,3 ,4 ]
机构：
[1] Yale Sch Med, Sect Cardiovasc Med, Dept Med, New Haven, CT USA
[2] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Boston, MA 02215 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02115 USA
[4] Baim Inst Clin Res, Boston, MA USA
[5] Medtronic, Minneapolis, MN USA
来源：
CIRCULATION | 2020年 / 142卷 / 03期
关键词：
administrative claims; healthcare; clinical trial; coronary artery disease;
D O I：
10.1161/CIRCULATIONAHA.120.047729
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：306 / 308
页数：3
相关论文
共 50 条
  • [1] Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study
    Faridi, Kamil F. F.
    Strom, Jordan B. B.
    Kundi, Harun
    Butala, Neel M. M.
    Curtis, Jeptha P. P.
    Gao, Qi
    Song, Yang
    Zheng, Luke
    Tamez, Hector
    Shen, Changyu
    Secemsky, Eric A. A.
    Yeh, Robert W. W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (14):
  • [2] Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study Findings From the EXTEND-DAPT Study
    Faridi, Kamil F.
    Tamez, Hector
    Butala, Neel M.
    Song, Yang
    Shen, Changyu
    Secemsky, Eric A.
    Mauri, Laura
    Curtis, Jeptha P.
    Strom, Jordan B.
    Yeh, Robert W.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (01): : 68 - 75
  • [3] Individualizing Treatment Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: An Analysis of the DAPT Study
    Yeh, Robert W.
    Secemsky, Eric
    Kereiakes, Dean J.
    Gershlick, Anthony
    Cohen, David J.
    Spertus, John A.
    Steg, Philippe G.
    Cutlip, Donald E.
    Apruzzese, Patricia K.
    Massaro, Joseph M.
    Mauri, Laura
    CIRCULATION, 2015, 132 (23) : 2272 - 2273
  • [4] ASSESSING FRAILTY-ASSOCIATED CHARACTERISTICS AND OUTCOMES IN THE DUAL ANTIPLATELET THERAPY (DAPT) STUDY USING MEDICARE CLAIMS: INSIGHTS FROM THE EXTEND-DAPT STUDY
    Faridi, Kamil
    Kundi, Harun
    Strom, Jordan B.
    Curtis, Jeptha P.
    Gao, Qi
    Song, Yang
    Aguilar, Hector Tamez
    Mauri, Laura
    Shen, Changyu
    Yeh, Robert W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 37 - 37
  • [5] One vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention
    Tan, Wei Keith
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (17): : 1715 - 1715
  • [6] Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Stenosis: 6 versus 12 Months
    Hartikainen, Tau Sarra
    Mertins, Sina
    Behrens, Max
    Neumann, Franz-Josef
    Valina, Christian Marc
    Loeffelhardt, Nikolaus
    Nedjat, Faridun Daniel Rahimi
    Breitbart, Philipp
    Franke, Kilian
    Westermann, Dirk
    Ferenc, Miroslaw
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [7] Frequency of the Use of Low- Versus High-Dose Aspirin in Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (from the Dual Antiplatelet Therapy Study)
    Matteau, Alexis
    Yeh, Robert W.
    Kereiakes, Dean
    Orav, E. John
    Massaro, Joseph
    Steg, P. Gabriel
    Normand, Sharon-Lise
    Cutlip, Donald E.
    Mauri, Laura
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07): : 1146 - 1152
  • [8] Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the Guthrie PCI Registry
    Harjai, K. J.
    Shenoy, C.
    Orshaw, P.
    Boura, J.
    HEART, 2009, 95 (19) : 1579 - 1586
  • [9] Will this trial change my practice? The Dual Antiplatelet Therapy (DAPT) study-12 or 30 months of dual antiplatelet therapy after drug-eluting stents
    Grundeken, Maik J.
    Lansky, Alexandra
    Tanguay, Jean-Francois
    Gershlick, Anthony
    Baumbach, Andreas
    Cuisset, Thomas
    EUROINTERVENTION, 2015, 11 (03) : 364 - 365
  • [10] Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention
    Piccolo, Raffaele
    Gargiulo, Giuseppe
    Franzone, Anna
    Santucci, Andrea
    Ariotti, Sara
    Baldo, Andrea
    Tumscitz, Carlo
    Moschovitis, Aris
    Windecker, Stephan
    Valgimigli, Marco
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (01) : 17 - +
12345